The Hackett Group (HCKT) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Q2 2025 revenue reached $78.9M, up 1.6% year-over-year, exceeding guidance, with adjusted EPS of $0.38 at the midpoint and GAAP net income of $1.7M, down from $8.7M due to higher costs and stock-based compensation.
Growth was driven by Gen AI-related consulting and platform innovation, especially in the Global S&BT segment, while Oracle Solutions faced headwinds from delayed client projects.
Strategic innovation included enhancements to AI Explorer, ZBrain Gen AI, and the accelerated release of AI XPLR V4.
Acquisitions of LeewayHertz and Spend Matters expanded AI and procurement capabilities, with a joint venture for Gen AI orchestration.
The company is aggressively pivoting to Gen AI-enabled transformation, viewing it as a generational opportunity for consulting and technology services.
Financial highlights
Total Q2 2025 revenue was $78.9M, up from $77.7M year-over-year; revenue before reimbursements was $77.6M.
Adjusted net income was $10.7M, with adjusted diluted EPS of $0.38, compared to $0.39 last year.
GAAP net income was $1.7M ($0.06 per share), down from $8.7M ($0.31 per share) due to non-cash stock compensation and acquisition-related expenses.
Adjusted EBITDA was $16.1M, or 20.7% of revenues before reimbursements.
Cash flow from operations was $5.65M in Q2; cash balance at quarter-end was $10.1M.
Outlook and guidance
Q3 2025 revenues before reimbursements expected between $73M and $74.5M.
Adjusted EPS guidance for Q3 is $0.36–$0.38; adjusted gross margin expected at 43.5%–44.5%.
Restructuring charges of $1.5–$2M in Q3 due to headcount reductions aligned with Gen AI productivity gains.
Global S&BT and SAP Solutions segments projected to grow year-over-year; Oracle Solutions expected to decline over 20%.
The company is assessing the impact of the One Big Beautiful Bill Act on its financials.
Latest events from The Hackett Group
- Annual meeting to vote on director, stock plan amendment, compensation, and auditor ratification.HCKT
Proxy filing20 Mar 2026 - Proxy covers director election, compensation, stock plan amendment, and auditor ratification.HCKT
Proxy filing20 Mar 2026 - Q4 2025 beat guidance with SAP and GenAI gains, but margins and EBITDA declined year-over-year.HCKT
Q4 202517 Feb 2026 - Q2 revenue and EPS exceeded guidance, with Gen AI investments and strong cash flow.HCKT
Q2 20242 Feb 2026 - Q3 revenue and adjusted EPS beat guidance; GenAI growth accelerated by LeewayHertz acquisition.HCKT
Q3 202417 Jan 2026 - Q4 results beat guidance on SAP and GenAI strength; GenAI investments to drive 2025 growth.HCKT
Q4 202423 Dec 2025 - Shareholders will vote on director elections, stock plan expansion, executive pay, and auditor ratification.HCKT
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, stock plan amendment, compensation, and auditor.HCKT
Proxy Filing2 Dec 2025 - GenAI-fueled growth drove strong Q1 results, despite lower net income from higher expenses.HCKT
Q1 202521 Nov 2025